Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-02-14 | New | $4,818,026 | $4,818,026 | Equity Only | 06b | SEC link |
| 2021-10-20 | New | $8,500,000 | $8,500,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Gregory Cresenzi | Executive |
| Matthew Gunnison | Director |
| Jonathan Hartmann | Director, Executive |
| Debrah Herman | Executive |
| John C. Ho | Director |
| David Carr Michael | Director |
| David Michael Seldin | Director |